Table: begin end state 1 29 non-cytoplasmic 30 51 transmembrane 52 57 cytoplasmic 58 82 transmembrane 83 88 non-cytoplasmic 89 111 transmembrane 112 122 cytoplasmic 123 124 transmembrane 125 125 cytoplasmic 126 145 transmembrane 146 155 non-cytoplasmic 156 175 transmembrane 176 184 cytoplasmic 185 205 transmembrane 206 219 non-cytoplasmic 220 242 transmembrane 243 253 cytoplasmic 254 281 transmembrane 282 300 non-cytoplasmic 301 324 transmembrane 325 349 cytoplasmic 350 372 transmembrane 373 377 non-cytoplasmic 378 397 transmembrane 398 408 cytoplasmic 409 429 transmembrane 430 434 non-cytoplasmic 435 453 transmembrane 454 464 cytoplasmic
Input: >RR42_RS01585 FitnessBrowser__Cup4G11:RR42_RS01585 MSLFRTKNIEAMLAAARDDGLKKVLGPVDLILMGIGAIIGTGIFVLTGTGALTAGPALTV SFVIAALACGFAALCYAEFASAIPVSGSIYTYSYATLGEIVAWMIGWDLLLEYGLATSAV SVGWSGYFQSLMAGFGIHLPAMLTAAPGAVPGVQTLFNLPAAVIMLLITWVVSYGVRESA RLNNVMVAVKIAVVLLFIGVGVWHVKPANWHPFAPFGLDGVFNAAALVFFAFIGFDAVTS AAEEVRNPRRDLPIGIIGSLAVCTVLYVTVAAIMTGIVPFAKFAGIDHPVSLALQYAGEN WVAGFVDLGAILGMTTVILVMTFGQTRIIFAMSRDGLLPERLSTVHPVHATPFFATWTVG IVFAFIAAFVPLNVLAELINIGTLSAFTLISVAVLVLRKTRPDLPRAFRCPGVPVVPLLS VGFCLFLMAHLQALTWVAFLAWLAIGLAIYFLYARRNAVLHGGA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server